A G Protein-coupled Receptor Responsive to Bile Acids
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
So far some nuclear receptors for bile acids have been identified. However, no cell surface receptor for bile acids has yet been reported. We found that a novel G protein-coupled receptor, TGR5, is responsive to bile acids as a cell-surface receptor. Bile acids specifically induced receptor internalization, the activation of extracellular signal-regulated kinase mitogen-activated protein kinase, the increase of guanosine 5'-O-3-thio-triphosphate binding in membrane fractions, and intracellular cAMP production in Chinese hamster ovary cells expressing TGR5. Our quantitative analyses for TGR5 mRNA showed that it was abundantly expressed in monocytes/macrophages in human and rabbit. Treatment with bile acids was found to suppress the functions of rabbit alveolar macrophages including phagocytosis and lipopolysaccharide-stimulated cytokine productions. We prepared a monocytic cell line expressing TGR5 by transfecting a TGR5 cDNA into THP-1 cells that did not express TGR5 originally. Treatment with bile acids suppressed the cytokine productions in the THP-1 cells expressing TGR5, whereas it did not influence those in the original THP-1 cells, suggesting that TGR5 is implicated in the suppression of macrophage functions by bile acids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, KO of the BA receptors FXR (Nr1h4), TGR5 (Gpbar1), and VDR (Vdr) (36-38) did not rescue T cell function in LCA-fed mice (fig. S10, F and G).”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [36]
In the citing paper
“activation of GPBAR1 on macrophages and Kupffer cells by synthetic agonists inhibits the expression of LPS-induced pro-inflammatory cytokines by interfering with NF-κB-dependent transcription.”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“Both receptors can be activated by primary and secondary bile acids alike (Kawamata et al., 2003; Makishima et al., 1999; Maruyama et al., 2002; Parks et al., 1999; H. Wang et al., 1999).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“GPBAR1, as the name suggests, is a Gs-protein-coupled receptor. Binding by bile acids triggers an increase in intracellular cAMP levels and the activation of ERK (Kawamata et al., 2003; Maruyama et al., 2002).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“This has been linked to direct inhibition of NF-κB activation, but is also consistent with a model of transcriptional competition between NF-κB and the cAMP-activated transcription factor cAMP response element binding protein (CREB) (C. Guo et al., 2015; Kawamata et al., 2003; Keitel et al., 2008; Pols et al., 2011; Y.-D. Wang et al., 2011; Wen et al., 2010).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J., & Damron, D. S. (2000) · Nature Cell Biology · doi:10.1038/35010529 · Cited by 289
RetractedCD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
SOSUI: classification and secondary structure prediction system for membrane proteins.
Hirokawa, T., Boon-Chieng, S., & Mitaku, S. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.4.378 · Cited by 1,936
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.27 · Cited by 672
Research works printed but not linked: 3
- Jones, 2000, Mol. Endocrinol., 14, 27, 10.1210/mend.14.1.0409 · doi:10.1210/mend.14.1.0409 · Paper page
- Keane, 1984, Surgery, 95, 439
- Kimmings, 1995, J. Am. Coll. Surg., 181, 567
Cited by
Items 601–700 of 1,002
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Zhou, J., Tripathi, M., Sinha, R. A., Singh, B. K., & Yen, P. M. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.134 · Cited by 63
“TGR5 also was expressed in monocytes, macrophages, and Kupffer cells, and modulated immune response[73,75].”
BackgroundInfluentialLinking liver metabolic and vascular disease via bile acid signaling
Fiorucci, S., & Distrutti, E. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.10.005 · Cited by 49
Incretin Hormones, Obesity and Gut Microbiota
Angelini, G., Russo, S., & Mingrone, G. (2024) · Peptides · doi:10.1016/j.peptides.2024.171216 · Cited by 47
“The microbiota plays a crucial role in bile acid-dependent L-cell activation by deconjugating bile acids to enhance their permeability and by dehydroxylating them to increase their action on GPBAR1 [100].”
BackgroundAirway microbiome-immune crosstalk in chronic obstructive pulmonary disease
Kayongo, A., Robertson, N. M., Siddharthan, T., Ntayi, M. L., Ndawula, J. C., Sande, O. J., Bagaya, B. S., Kirenga, B., Mayanja‐Kizza, H., Joloba, M. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1085551 · Cited by 60
Bile acids: emerging role in management of liver diseases
Asgharpour, A., Kumar, D. P., & Sanyal, A. J. (2015) · Hepatology International · doi:10.1007/s12072-015-9656-7 · Cited by 49
“Takeda G-protein coupled receptor clone 5 (TGR5), also known as GPBAR1, M-BAR or BG37, was first discovered in 2002 by two independent research groups in Japan [35, 36].”
BackgroundFryer, R. M., Ng, K. J., Mazurek, S. N., Patnaude, L. A., Skow, D. J., Muthukumarana, A. C., Gilpin, K. E., Dinallo, R. M., Kuzmich, D., Lord, J., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.210005 · Cited by 49
“These represent measures of GPBAR1 agonism as previously published (Kawamata et al., 2003; Wang et al., 2011).”
MethodUnifying Mechanisms of Action of the Anticancer Activities of Triterpenoids and Synthetic Analogs
Safe, S. H., Prather, P. L., Brents, L. K., Chadalapaka, G., & Jutooru, I. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833099 · Cited by 47
“Like FXR, TGR5 binds diverse bile acids; however, this receptor is a GPCR and a member of the rhodopsin-like superfamily [89, 90].”
BackgroundKobayashi, Y., Hara, N., Sugimoto, R., Mifuji‐Moroka, R., Tanaka, H., Eguchi, A., Iwasa, M., Hasegawa, H., Iwata, K., Takei, Y., et al. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7796 · Cited by 47
“In addition, BAs bind to the membrane-type receptor TGR5, which is involved in the secretion of incretin hormone glucagon-like peptide and the regulation of energy homeostasis (5, 8, 10).”
BackgroundDenny, J. E., Powers, J. B., Castro, H. F., Zhang, J., Joshi‐Barve, S., Campagna, S. R., & Schmidt, N. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-40266-6 · Cited by 58
Muscle-specific TGR5 overexpression improves glucose clearance in glucose-intolerant mice
Sasaki, T., Watanabe, Y., Kuboyama, A., Oikawa, A., Shimizu, M., Yamauchi, Y., & Sato, R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.016203 · Cited by 51
Zhang, L., Miao, C., Wang, Z., Guan, X., Ma, Y., Song, J., Shen, S., Song, H., Li, M., & Liu, C. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155416 · Cited by 47
Update on the development of TGR5 agonists for human diseases
Jin, W., Zheng, M., Chen, Y., & Xiong, H. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116462 · Cited by 50
Biagioli, M., Carino, A., Fiorucci, C., Marchianò, S., Di Giorgio, C., Bordoni, M., Roselli, R., Baldoni, M., Distrutti, E., Zampella, A., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901427 · Cited by 48
Role of Nuclear Receptors in Lipid Dysfunction and Obesity-Related Diseases
Swanson, H. I., Wada, T., Xie, W., Renga, B., Zampella, A., Distrutti, E., Fiorucci, S., Kong, B., Thomas, A., Guo, G. L., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048694 · Cited by 47
De Marino, S., Carino, A., Masullo, D., Finamore, C., Marchianò, S., Cipriani, S., Di Leva, F. S., Catalanotti, B., Novellino, E., Limongelli, V., et al. (2017) · Scientific Reports · doi:10.1038/srep43290 · Cited by 44
“1), with EC 50 of 0.53 μ M and 0.29 μ M, respectively 22 .”
InfluentialBrønden, A., Albér, A., Rohde, U., Gasbjerg, L. S., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13080 · Cited by 46
“This notion seems to be in accordance with the physiology behind activation and subsequent response time of transmembrane G protein-coupled and nuclear receptors, respectively.(4,30) In contrast to our findings, Potthoff et al.”
ResultExcreted Steroids in Vertebrate Social Communication
Doyle, W. I., & Meeks, J. P. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2488-17.2018 · Cited by 48
“Nuclear receptors (for review, see Evans and Mangelsdorf, 2014) and several steroid-sensitive plasma membrane receptors (Kawamata et al., 2003 for review, see Wang et al., 2014) are known to play important roles in mammalian physiology.”
BackgroundLiang, H., Matei, N., McBride, D. W., Xu, Y., Tang, J., Luo, B., & Zhang, J. H. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00656-9 · Cited by 46
Redox‐Dependent Effects in the Physiopathological Role of Bile Acids
Orozco-Aguilar, J., Simón, F., & Cabello‐Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4847941 · Cited by 48
“Besides, the TGR5 activity associates with elevated intracellular calcium levels and cytosolic cyclic adenosine monophosphate (cAMP), independently of FXR activation [40, 41].”
BackgroundChen, W.-D., Yu, D. D., FORMAN, B. M., Huang, W., & Wang, Y.-D. (2012) · Hepatology · doi:10.1002/hep.26019 · Cited by 51
RetractedLi, C., Li, J., Weng, X., Lan, X., & Chi, X. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.04.006 · Cited by 47
Keitel, V., & Häussinger, D. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835f3f14 · Cited by 45
“Copyright © Lippincott Williams & Wilkins.”
BackgroundInfluentialNovel bile acid therapeutics for the treatment of chronic liver diseases
Hegade, V. S., Speight, R. A., Etherington, R. E., & Jones, D. E. J. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16630712 · Cited by 44
Pham, H. T., Arnhard, K., Asad, Y. J., Deng, L., Felder, T. K., St John-Williams, L., Kaever, V., Leadley, M., Mitro, N., Muccio, S., et al. (2016) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.020537 · Cited by 43
Mythen, S. M., Devendran, S., Méndez–García, C., Cann, I., & Ridlon, J. M. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02475-17 · Cited by 48
“The generation of oxo-bile acids is known to inhibit host enzymes involved in glucocorticoid metabolism and may alter signaling through nuclear receptors such as farnesoid X receptor and G-proteincoupled receptor TGR5.”
BackgroundFranco, P., Porru, E., Fiori, J., Gioiello, A., Cerra, B., Roda, G., Caliceti, C., Simoni, P., & Roda, A. (2018) · Journal of Chromatography A · doi:10.1016/j.chroma.2018.11.038 · Cited by 44
The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
Lefort, C., & Cani, P. D. (2021) · Cells · doi:10.3390/cells10020400 · Cited by 42
“Its strongest endogenous agonist includes LCA and, to a lesser extent, (un)conjugated DCA, CDCA, UDCA and CA [81,82].”
BackgroundGut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions
Varricchi, G., Poto, R., Ianiro, G., Punziano, A., Marone, G., Gasbarrini, A., & Spadaro, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712915 · Cited by 51
Bile Acids Have the Gall to Function as Hormones
Vallim, T. Q. D. A., & Edwards, P. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.005 · Cited by 46
“In yet another surprise, specific bile acids were shown in 2002–2003 to activate a cell surface G protein-coupled receptor, now named TGR5, and to increase cellular cAMP levels (Maruyama et al., 2006; Kawamata et al., 2003).”
BackgroundIntercellular Lipid Mediators and GPCR Drug Discovery
Im, D. (2013) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2013.080 · Cited by 45
“TGR5 (now renamed GPBA) is a receptor for bile acids (Maruyama et al., 2002; Kawamata et al., 2003), and thus, bile acids signal not only through nuclear hormone receptors, such as, farnesoid X receptor α (FXR-α), but also through GPBA.”
BackgroundMicrobiota and epigenetics: promising therapeutic approaches?
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15623-6 · Cited by 47
“Another example of beneficial metabolites is the secondary bile acids resulting from the metabolization of bile acids by the microbiota (Kawamata et al. 2003).”
BackgroundTGR5 deficiency in excitatory neurons ameliorates Alzheimer’s pathology by regulating APP processing
Li, C., Wang, L., Xie, W., Chen, E., Chen, Y., Li, H., Can, D., Lei, A., Wang, Y., & Zhang, J. (2024) · Science Advances · doi:10.1126/sciadv.ado1855 · Cited by 57
“TGR5 is the first known G protein–coupled receptor specific for BAs, also known GPBAR1, consisting of 330 amino acids ( 27 , 28 ).”
BackgroundProbing the Binding Site of Bile Acids in TGR5
Macchiarulo, A., Gioiello, A., Thomas, C., Pols, T. W. H., Nuti, R., Ferrari, C., Giacchè, N., Franco, F., Pruzanski, M., Auwerx, J. H., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400247k · Cited by 47
Intestinal Secretory Mechanisms in Irritable Bowel Syndrome–Diarrhea
Camilleri, M. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.020 · Cited by 45
Ladurner, A., Zehl, M., Grienke, U., Hofstadler, C., Faur, N., Pereira, F. C., Berry, D., Dirsch, V. M., & Rollinger, J. M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00468 · Cited by 43
“…triterpenes oleanolic acid and maslinic acid have been shown to improve glucose homeostasis and suppress postprandial hyperglycemia in diabetic rats via inhibition of carbohydrate hydrolysis and reduction of glucose transporters in the gastrointestinal tract (Khathi et al., 2013).”
BackgroundUpdate on Bile Acid Malabsorption: Finally Ready for Prime Time?
Vijayvargiya, P., & Camilleri, M. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0615-z · Cited by 47
Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles
Zhang, B., Kuipers, F., de Boer, J. F., & Kuivenhoven, J. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010004 · Cited by 46
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review
Cunha, T. D., Vaziri, H., & Wu, G. Y. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00344 · Cited by 49
Synthesis, Characterization, and Receptor Interaction Profiles of Enantiomeric Bile Acids
Katona, B. W., Cummins, C. L., Ferguson, A. D., Li, T., Schmidt, D. R., Mangelsdorf, D. J., & Covey, D. F. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0707931 · Cited by 45
Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease
WEI, J., QIU, D. K., & MA, X. (2009) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2009.00369.x · Cited by 43
Gioiello, A., Macchiarulo, A., Carotti, A., Filipponi, P., Costantino, G., Rizzo, G., Adorini, L., & Pellicciari, R. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.004 · Cited by 46
Arya Devi, K. P., & Martin, A. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2026873 · Cited by 45
Minerbi, A., González, E., Brereton, N. J. B., Fitzcharles, M., Chevalier, S., & Shir, Y. (2022) · Pain · doi:10.1097/j.pain.0000000000002694 · Cited by 44
Effects of Chemical Modification of Ursodeoxycholic Acid on TGR5 Activation
Iguchi, Y., Nishimaki‐Mogami, T., Yamaguchi, M., Teraoka, F., Kaneko, T., & Une, M. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1 · Cited by 44
Role of Bile Acids and the Biliary HCO3− Umbrella in the Pathogenesis of Primary Biliary Cholangitis
van Niekerk, J., Kersten, R., & Beuers, U. H. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.03.013 · Cited by 43
Activation of TGR5 promotes osteoblastic cell differentiation and mineralization
Wang, Q., Wang, G., Wang, B., & Yang, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.093 · Cited by 44
Lysophosphatidic acid activates satellite glia cells and Schwann cells
Robering, J. W., Gebhardt, L., Wolf, K., Kühn, H., Kremer, A. E., & Fischer, M. J. M. (2019) · Glia · doi:10.1002/glia.23585 · Cited by 44
Petrov, P., García‐Mediavilla, M. V., Guzmán, C., Porras, D., Nistal, E., Martínez‐Flórez, S., Castell, J. V., González‐Gallego, J., Sánchez‐Campos, S., & Jover, R. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900487 · Cited by 44
Cancer-Associated Cachexia: A Systemic Consequence of Cancer Progression
Biswas, A., & Acharyya, S. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033642 · Cited by 47
“Gut microbiota have recently been shown to metabolize bile acids (Wahlstrom et al. 2016), which are known to enhance fat absorption in the intestine and regulate fat metabolism by acting as signaling molecules and metabolic integrators (Bindels & Delzenne 2013, Kawamata et al. 2003).”
Background2‐Phenoxy‐nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5)
Martin, R. E., Bissantz, C., Gavelle, O., Kuratli, C., Dehmlow, H., Richter, H. G. F., Obst-Sander, U., Erickson, S. D., Kim, K., Pietranico‐Cole, S. L., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200474 · Cited by 43
Bile acids attenuate PKM2 pathway activation in proinflammatory microglia
Romero-Ramírez, L., García-Rama, C., Wu, S., & Mey, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-05408-3 · Cited by 41
“01] and PKM2 (b) in microglial cells [F(5, 29) = 13.”
Type 2 Diabetes and the Microbiome
Barlow, G. M., & Mathur, R. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac184 · Cited by 49
“The effects of primary bile acids are mediated through farnesoid X receptor, whereas the effects on secondary bile acids are mediated through Takeda G-protein-coupled receptor [34, 71, 72].”
BackgroundInsights by which TUDCA is a potential therapy against adiposity
Freitas, I. N., junior, J. A. D. S., de Oliveira, K. M., Alves, B. L., Araújo, T. R., Camporez, J. P., Carneiro, E. M., & Davel, A. P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1090039 · Cited by 45
Effect of maternal cholestasis on TGR5 expression in human and rat placenta at term
Keitel, V., Spomer, L., Marín, J. J. G., Williamson, C., Geenes, V. L., Kubitz, R., Häussinger, D., & Macías, R. I. R. (2013) · Placenta · doi:10.1016/j.placenta.2013.06.302 · Cited by 43
“The presence of TGR5 in Hofbauer cells is not surprising because this receptor has been previously detected in macrophages of other organs [11,18,28].”
BackgroundKrattinger, R., Boström, A. E. D., Lee, S. M. L., Thasler, W. E., Schiöth, H. B., Kullak-Ublick, G. A., & Mwinyi, J. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.04.037 · Cited by 43
Ursodeoxycholic acid inhibits TNFα-induced IL-8 release from monocytes
O’Dwyer, A. M., Lajczak, N., Keyes, J. A., Ward, J. B. J., Greene, C. M., & Keely, S. J. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00406.2015 · Cited by 41
“This, along with previous reports of the low potency of UDCA at TGR5 (19), suggests it is unlikely that this receptor mediates effects of the bile acid reported in the current studies, A role for FXR also seems unlikely since it has been previously shown not to be expressed in U937 cells (29), a finding confirmed by o…”
ResultMobraten, K., Haugbro, T., Karlstrom, E., Kleiveland, C. R., & Lea, T. (2014) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2014.986744 · Cited by 42
“TGR5 is a GPCR that is previously reported to couple to Gs which leads to increased cAMP levels (5).”
BackgroundInfluentialGustducin couples fatty acid receptors to GLP-1 release in colon
Li, Y., Kokrashvili, Z., Mosinger, B., & Margolskee, R. F. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2012 · Cited by 37
“High levels of TGR5 mRNA are detected in spleen, lung, liver, stomach, intestine, adipose tissue, gallbladder, and bone marrow in human and mouse (39, 66).”
Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment
Zaborska, K. E., & Cummings, B. P. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1092-3 · Cited by 43
Li, R., Zeng, L., Xie, S., Chen, J., Yu, Y., & Zhong, L. (2019) · PeerJ · doi:10.7717/peerj.7145 · Cited by 47
“Farnesoid X receptor is the most important bile acid receptor, not only expressed in the enterohepatic circulation, but also in the heart and kidneys (Forman et al., 1995; Kawamata et al., 2003).”
BackgroundSemisynthetic bile acids: a new therapeutic option for metabolic syndrome
Lazarević, S., Đanić, M., Goločorbin-Kon, S., Al‐Salami, H., & Mikov, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104333 · Cited by 42
Overview of bile acid signaling in the cardiovascular system
Zhang, R., Ma, W., Fu, M., Li, J., Hu, C., Chen, Y., Zhou, M., Gao, Z., & He, Y. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i2.308 · Cited by 44
Bile Acid Metabolism in Health and Disease
Li, T., & Chiang, J. Y. L. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch23 · Cited by 42
Bile acids induce arrhythmias: old metabolite, new tricks
Desai, M. S., & Penny, D. J. (2013) · Heart · doi:10.1136/heartjnl-2013-304546 · Cited by 40
Mechanisms Underlying the Anti-Aging and Anti-Tumor Effects of Lithocholic Bile Acid
Arlia‐Ciommo, A., Piano, A., Svistkova, V., Mohtashami, S., & Titorenko, V. I. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150916522 · Cited by 40
“agonist [141,149,182,183], triggers three different pathways that compromise viability and/or proliferation of human neuroblastoma cells.”
BackgroundNielsen, S., Svane, M. S., Kuhre, R. E., Clausen, T. R., Kristiansen, V. B., Rehfeld, J. F., Holst, J. J., Madsbad, S., & Bojsen‐Moller, K. N. (2017) · Physiological Reports · doi:10.14814/phy2.13140 · Cited by 40
“Dose-response studies of different BAs with respect to GLP-1 secretion have not been performed in humans, but an in vitro study has demonstrated that CDCA activates TGR5 while UDCA was without effect (at equal concentrations) (Kawamata et al. 2003).”
BackgroundBeneficial effects of bile acid receptor agonists in pulmonary disease models
Comeglio, P., Morelli, A., Adorini, L., Maggi, M., & Vignozzi, L. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1385760 · Cited by 43
“Interestingly, TGR5 has been documented also in the lung, mainly localized in alveolar macrophages [45,53].”
BackgroundInfluentialDistribution and Stimulus Secretion Coupling of Enteroendocrine Cells along the Intestinal Tract
Adriaenssens, A. E., Reimann, F., & Gribble, F. M. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170047 · Cited by 41
Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity
Ahlin, S., CEFALO, C. M. A., Bondia‐Pons, I., Capristo, E., Marini, L., Gastaldelli, A., Mingrone, G., & Nolan, J. J. (2019) · British journal of surgery · doi:10.1002/bjs.11208 · Cited by 41
Bile acids LCA and CDCA inhibited porcine deltacoronavirus replication in vitro
Kong, F., Niu, X., Liu, M., & Wang, Q. (2021) · Veterinary Microbiology · doi:10.1016/j.vetmic.2021.109097 · Cited by 40
Multi-omics: Opportunities for research on mechanism of type 2 diabetes mellitus
Wang, S., Yong, H., & He, X. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i7.1070 · Cited by 47
FXR Promotes Endothelial Cell Motility Through Coordinated Regulation of FAK and MMP-9
Das, A., Yaqoob, U., Mehta, D., & Shah, V. H. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.182725 · Cited by 40
McMillin, M., Grant, S., Frampton, G., Petrescu, A. D., Kain, J., Williams, E., Haines, R., Canady, L., & DeMorrow, S. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.02.008 · Cited by 38
Bile Formation and the Enterohepatic Circulation
Dawson, P. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00053-1 · Cited by 40
Zhao, Y., Wei, S., Chen, L., Zhou, X., & Ma, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1164202 · Cited by 45
Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome
Gou, X., Qin, L., Wu, D., Xie, J. W., Lu, Y., Zhang, Q., & He, Y. (2023) · Molecules · doi:10.3390/molecules28155870 · Cited by 39
“When macrophages remove the modified forms of LDL-C from the vascular wall, it eventually forms foam cells and produces local inflammatory factors and chemokines, causing chronic inflammation in the vascular wall and promoting lipid accumulation in the cells [24].”
BackgroundInfluentialHong, J., Behar, J., Wands, J., Resnick, M., Wang, L. J., DeLellis, R. A., Lambeth, D., & Cao, W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2774 · Cited by 38
“Phosphatidylinositol-specific phospholipase C (PI-PLC) has been reported to be activated by the Gαq protein family (24, 25).”
BackgroundCarino, A., Marchianò, S., Biagioli, M., Fiorucci, C., Zampella, A., Monti, M. C., Morretta, E., Bordoni, M., Giorgio, C. D., Roselli, R., et al. (2019) · Nutrients · doi:10.3390/nu11051132 · Cited by 38
“GPBAR1 is a cell surface receptor for secondary bile acids highly expressed in muscles, adipocytes, intestinal cells, and non-parenchymal liver cells, essentially liver resident macrophages and NKT cells [9,10,12].”
BackgroundBile Acids: Key Regulators and Novel Treatment Targets for Type 2 Diabetes
Wu, Y., Zhou, A., Tang, L., Lei, Y., Tang, B., & Zhang, L. (2020) · Journal of Diabetes Research · doi:10.1155/2020/6138438 · Cited by 45
Yang, H., Luo, F., Wei, Y., Jiao, Y., Qian, J., Chen, S., Gong, Y. L., & Tang, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2631 · Cited by 39
Shah, N. Z., Abdalla, M. A., Deshmukh, H., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211042145 · Cited by 44
Herráez, E., Lozano, E., Poli, E., Keitel, V., Luca, D. D., Williamson, C., Marín, J. J. G., & Macías, R. I. R. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1106-1 · Cited by 39
Avet, C., Mancini, A. D., Breton, B., Gouill, C. L., Hauser, A. S., Normand, C., Kobayashi, H., Gross, F., Hogue, M., Lukasheva, V., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3586569 · Cited by 40
Gong, L., Liu, F., Liu, J., & Wang, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128835 · Cited by 45
TGR5 Sequence Variation in Primary Sclerosing Cholangitis
Hov, J. R., Keitel, V., Schrumpf, E., Häussinger, D., & Karlsen, T. H. (2011) · Digestive Diseases · doi:10.1159/000324138 · Cited by 35
“Exploration of the UC and PSC GWAS dataset showed that this overlapping association signal in PSC and UC stretched across a genetic region of more than 200 kbp, covering eight genes (table 1 ). The TGR5 gene was of particular interest, given the link between intestinal and biliary disease in patients with PSC. 1 Table…”
BackgroundHallmarks of the human intestinal microbiome on liver maturation and function
Almeida, J. I., Tenreiro, M. F., Martínez‐Santamaría, L., Guerrero‐Aspizua, S., Gisbert, J. P., Alves, P. M., Serra, M., & Baptista, P. M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.015 · Cited by 42
Marchianò, S., Biagioli, M., Morretta, E., Giorgio, C. D., Roselli, R., Bordoni, M., Bellini, R., Urbani, G., Massa, C., Monti, M. C., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-28647-4 · Cited by 39
Pharmacophore model for bile acids recognition by the FPR receptor
Ferrari, C., Macchiarulo, A., Costantino, G., & Pellicciari, R. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9055-1 · Cited by 37
Akwabi-Ameyaw, A., Caravella, J. A., Chen, L., Creech, K. L., Deaton, D. N., Madauss, K. P., Marr, H. B., Miller, A. B., Navas, F., Parks, D. J., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.034 · Cited by 37
Cholestatic Liver Diseases from Child to Adult: The Diversity of MDR3 Disease
Kubitz, R., Bode, J. G., Erhardt, A., Graf, D., KIRCHEIS, G., Müller‐Stöver, I., Reinehr, R., Reuter, S., Richter, J., Sagir, A., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0031-1273427 · Cited by 37
Chen, T., Reich, N. W., Bell, N., Finn, P. D., Rodriguez, D. J., Kohler, J. N., Kozuka, K., He, L., Spencer, A. G., Charmot, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00308 · Cited by 40
Enteroendocrine Cells: Metabolic Relays between Microbes and Their Host
Plovier, H., & Cani, P. D. (2017) · Endocrine Development · doi:10.1159/000475736 · Cited by 36
The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer’s Disease
Ehtezazi, T., Rahman, K., Davies, R., & Leach, A. G. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220071 · Cited by 41
“Takeda G protein receptor 5 (TGR5) is a cell-surface G protein coupled receptor, which is responsive to bile acids [272].”
BackgroundLv, W., Huang, J.-Y., Lin, J., Ma, Y., He, S.-Q., Zhang, Y., Wang, T.-Z., Cheng, K., Xiong, Y., Sun, F., et al. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/6409385 · Cited by 40
“TGR5 is a specific cell surface receptor that responds directly to BA and protects the liver from BA overload by controlling bile hydrophobicity and cytokine secretion [52, 53].”
BackgroundWang, L., Cheng, K., Li, Y., Niu, C., Cheng, J., & Niu, H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.087 · Cited by 36
Xiong, F., Wu, S., Lu, Q., Shi, M., Li, W., Zou, H., Li, M., & Wang, G. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.10.015 · Cited by 36
“In humans and mice, these three enzymes are strongly regulated by bile acid receptors named FXR (Makishima et al., 1999b) and TGR5 (Kawamata et al., 2003).”
BackgroundInfluentialLin, S., Yang, X., Long, Y., Zhong, H., Wang, P., Yuan, P., Zhang, X., Che, L., Feng, B., Li, J., et al. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520001774 · Cited by 39
“LCA is also a ligand of G protein coupled with bile acid receptor 1 (TGR5) and proposed to activate TGR5 more potent than DCA, CDCA and CA(37,38).”
BackgroundYang, X., Zhang, X., Yang, W., Yu, H., He, Q., Xu, H., Li, S., Shang, Z., Gao, X., Wang, Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.749125 · Cited by 36
Hou, J.-J., Wang, X., Wang, Y.-M., & Wang, B.-M. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.2018401 · Cited by 38
“Remarkably, the microbiotabased producing secondary Bas, as well as their conjugated forms, with the highest affinity for TGR5 (Kawamata et al. 2003).”
BackgroundBile Formation and the Enterohepatic Circulation
Dawson, P. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00041-4 · Cited by 44
Metadata
- Authors
- Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 11
- Pages
- 9435-9440
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2096418655
- Cited by
- 1,628
- References
- 27
- Citations by year
- 2026: 96 · 2025: 90 · 2024: 114 · 2023: 122 · 2022: 101 · 2021: 114 · 2020: 100 · 2019: 99 · 2018: 108 · 2017: 99 · 2016: 77 · 2015: 76 · 2014: 71 · 2013: 75 · 2012: 50
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6433 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- TGR5, G protein-coupled receptors, bile acids, cell surface receptors, receptor internalization, ERK MAP kinase, cAMP production, macrophages, monocytes, phagocytosis, cytokine production, lipopolysaccharide, THP-1 cells, alveolar macrophages
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Bile Acids and Salts, Cell Line, Cell Membrane, Dose-Response Relationship, Drug, Genetic Vectors, Cricetinae, Humans, Luminescent Proteins, Macrophages, Molecular Sequence Data, Phagocytosis, Protein Binding, Rabbits, Receptors, Cell Surface, Recombinant Fusion Proteins, RNA, Messenger, Time Factors, Tissue Distribution, Transfection, Cytokines, Guanosine 5'-O-(3-Thiotriphosphate), CHO Cells, GTP-Binding Proteins, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Receptors, G-Protein-Coupled, Green Fluorescent Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.